PetVivo Holdings PETV
OTC PETV
$0.69 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

PetVivo Holdings (PETV) Cash from Financing Activities (2010 - 2026)

Updated

PetVivo Holdings (PETV) posted Cash from Financing Activities of $900,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 80.9% from $4.71 million a year earlier and down 9.5% from the prior quarter.

Analysis

PetVivo Holdings (PETV) Cash from Financing Activities (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at PetVivo Holdings was $2.26 million, down 75.6% year-over-year; for FY2026 (ended Mar 31, 2026), it was $6.07 million, up 0.7% from FY2025.

  • Annual Cash from Financing Activities shows a five-year compound annual growth rate of 45.2% (FY2021 to FY2026).
  • In prior fiscal years, PetVivo Holdings' Cash from Financing Activities was $6.03 million in FY2025 (-17.9%), $7.34 million in FY2024 (+362.6%), $1.59 million in FY2023 (-84.8%) and $10.44 million in FY2022.
  • Quarterly Cash from Financing Activities has run from a low of -$348,081 in fiscal Q2 2026 to a high of $9.79 million in fiscal Q2 2022 over five years.
  • On a year-over-year basis, Cash from Financing Activities has declined in each of the last three quarters, with growth averaging 4.1% over the last seven quarters.
  • The strongest year-over-year quarter for Cash from Financing Activities in the past five years was fiscal Q4 2023, with growth of 454.9%; the weakest was fiscal Q2 2023, with a decline of 99.3%.
  • According to Business Quant data, Cash from Financing Activities for the three prior fiscal quarters was $995,000 (Q4 2026), $711,750 (Q3 2026) and -$348,081 (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,143.62 Bn 1,112.20 Bn 19.71 Bn 8.43 Bn
2 Johnson & Johnson 635.32 Bn 555.18 Bn 17.30 Bn -8.53 Bn
3 AbbVie 501.71 Bn 474.82 Bn 12.70 Bn -5.05 Bn
4 Merck 356.04 Bn 310.42 Bn 12.21 Bn 1.76 Bn
5 Novartis Ag 300.80 Bn 264.79 Bn 11.24 Bn -2.02 Bn
6 Astrazeneca 263.31 Bn 237.00 Bn 12.86 Bn -3.89 Bn
7 Amgen 238.70 Bn 194.10 Bn 7.24 Bn -1.48 Bn
8 Gilead Sciences 194.80 Bn 169.00 Bn 6.22 Bn 2.34 Bn
9 Pfizer 170.88 Bn 117.53 Bn 10.94 Bn -3.66 Bn
10 PetVivo Holdings 25.47 Mn 24.21 Mn 223,317.00 900,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 900,000.00
Mar 31, 2026 995,000.00
Dec 31, 2025 711,750.00
Sep 30, 2025 -348,081.00
Jun 30, 2025 4.71 Mn
Mar 31, 2025 1.95 Mn
Dec 31, 2024 887,500.00
Sep 30, 2024 1.72 Mn
Jun 30, 2024 1.47 Mn
Mar 31, 2024 1.56 Mn
Dec 31, 2023 1.50 Mn
Sep 30, 2023 2.32 Mn
Jun 30, 2023 1.95 Mn
Mar 31, 2023 1.53 Mn
Dec 31, 2022 -1,609.00
Sep 30, 2022 64,976.00
Jun 30, 2022 -1,563.00
Mar 31, 2022 274,851.00
Dec 31, 2021 -3,705.00
Sep 30, 2021 9.79 Mn
API Access

PetVivo Holdings Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PETV&period=max&api_key=YOUR_API_KEY